iBio Inc.
Exhibitor
Information
iBio is an innovator biologics company and global leader in plant-based biologics manufacturing. The company is developing therapeutics and vaccines that target systematic scleroderma (IBIO-100), classical swine fever (IBIO-400), and COVID-19 (IBIO-200 and IBIO-201). Its FastPharming System™ combines vertical farming, automated hydroponics, and glycan engineering technologies to rapidly deliver high-quality monoclonal antibodies, vaccines, bioinks, and other proteins with direct and consistent scalability. iBio's subsidiary, iBio CDMO LLC, provides FastPharming Contract Development and Manufacturing Services. Its FastGlycaneering Development Service™ includes an array of new glycosylation technologies for engineering high-performance recombinant proteins.
